Graham Capital Management, L.P. Verastem, Inc. Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $23,719 - $46,991	-22,377 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $45,872 - $71,606	22,377 New	22,377 $45,000
Q1 2021 May 17, 2021	SELL	$1.9 - $2.82 $3.55 Million - $5.26 Million	-1,866,687 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $150,216 - $313,495	-130,623 Reduced 6.54%	1,866,687 $3.98 Million
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $333,000 - $504,000	300,000 Added 17.68%	1,997,310 $2.42 Million
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $2.14 Million - $5.74 Million	1,697,310 New	1,697,310 $4.48 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.